Join fellow MedTech industry leaders, including CEOs, venture capitalists, in-house legal counsel and regulatory professionals, for a can't-miss, full-day program of insights, discussions, practical takeaways and networking focused on today's most pressing topics.

The event kicks off with breakfast, features a networking lunch and concludes with a post-event reception.

8:00 am: Breakfast | Registration | Networking

8:30 am: Welcome Remarks 

8:45 am – 9:45 am: Optimizing Service Providers while Transitioning from Early to Late Stage

• Speakers:
  • Patrice Kloss, Fox Rothschild, Moderator
  • Leota Pearson, Leota L Pearson Consulting, LLC
  • Lisa Pritchard, DuVal & Associates, P.A.
  • Ruth Vafek, Fox Rothschild
  • Megan Osorio, Veranex

9:45 am – 10:30 am: Putting AI to Work in Legal Practice: Practical Workflows, Ethics, and Risk Management

• Speaker:
  • Mark McCreary, Fox Rothschild

10:30 am – 10:45 am: Break

10:45 am – 11:15 am: Neurotech "State of the State" Session

• Speaker:
  • Jim Cavuoto, Publisher, Neurotech Reports

11:15 am – 12:15 pm: Sales & Marketing – Regulatory Trends

• Speakers:
  • Bryan Feldhaus, President, DuVal & Associates, P.A.
• Panel discussion:
  • Bob Freytag, Founding Partner, Introworks
  • Michael Kujak, President & CEO, Francis Medical

12:15 pm – 12:45 pm: Lunch | Networking

12:45 pm – 1:45 pm: Keynote: Update in FDA’s Regulation of Digital Health Technologies: How FDA is Approaching AI-Enabled Medical Devices

• Speaker:
  • Ambreen Athar, Senior Digital Health Advisor in the FDA's Division of Digital Health Policy
• Q&A panel: 
  • Mirko Raner, Software & Cybersecurity Consultant
  • Allison Komiyama, Senior Regulatory Strategist, DuVal & Associates, P.A.

1:45 pm – 2:45 pm: M&A Exits – Recent Trends

• Speaker:
  • Kathryn Dehn, Fox Rothschild

2:45 – 3:00 pm: Break

3:00 – 4:00 pm: Working Productively with FDA

• Speakers:
  • Mark DuVal, CEO, DuVal & Associates, P.A., Moderator
  • Chris Lyle, VP of Evidence Strategy, DuVal & Associates, P.A.
  • Allison Komiyama, Senior Regulatory Strategist, DuVal & Associates, P.A.
  • Lisa Pritchard, VP of Regulatory, Quality, Clinical and Engineering, DuVal & Associates, P.A.
  • Bryan Feldhaus, President, DuVal & Associates, P.A.
• Q&A panel: 
  • Ambreen Athar, Senior Digital Health Advisor in the FDA's Division of Digital Health Policy

4:00 pm: Closing Remarks | Cocktail Reception